New Results
Determination of Slow-binding HDAC Inhibitor Potency and Subclass Selectivity
View ORCID ProfileCarlos Moreno-Yruela, View ORCID ProfileChristian A. Olsen
doi: https://doi.org/10.1101/2021.12.18.473277
Carlos Moreno-Yruela
Center for Biopharmaceuticals & Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen DK-2100, Copenhagen, Denmark
Christian A. Olsen
Center for Biopharmaceuticals & Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen DK-2100, Copenhagen, Denmark
Article usage
Posted March 02, 2022.
Determination of Slow-binding HDAC Inhibitor Potency and Subclass Selectivity
Carlos Moreno-Yruela, Christian A. Olsen
bioRxiv 2021.12.18.473277; doi: https://doi.org/10.1101/2021.12.18.473277
Subject Area
Subject Areas
- Biochemistry (12804)
- Bioengineering (9688)
- Bioinformatics (31292)
- Biophysics (16113)
- Cancer Biology (13193)
- Cell Biology (18871)
- Clinical Trials (138)
- Developmental Biology (10217)
- Ecology (15200)
- Epidemiology (2067)
- Evolutionary Biology (19415)
- Genetics (12889)
- Genomics (17788)
- Immunology (12917)
- Microbiology (30224)
- Molecular Biology (12617)
- Neuroscience (65957)
- Paleontology (487)
- Pathology (2042)
- Pharmacology and Toxicology (3519)
- Physiology (5455)
- Plant Biology (11308)
- Synthetic Biology (3124)
- Systems Biology (7770)
- Zoology (1758)